MARCEL DANIEL BINGHAM M.D. NPI 1073592440

NPI Information

  • NPI: 1073592440
  • Provider Name: MARCEL DANIEL BINGHAM, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • Address: 5008 BRITTONFIELD PKWY
    SUITE 700
    EAST SYRACUSE, NY
    ZIP 13057
  • Phone: (315) 472-7504

Map and Directions

Get Directions

NPI Details

Marcel Daniel Bingham, M.D. is a hematology and oncology internal medicine in East Syracuse, NY. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Marcel Daniel Bingham, M.D. NPI is 1073592440. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

5008 BRITTONFIELD PKWY
SUITE 700
EAST SYRACUSE, NY
ZIP 13057
Phone: (315) 472-7504
Fax: (315) 479-8639

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1561)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Protein measurement, serum (HCPCS:84165)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Unclassified drugs (HCPCS:J3490)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Ct scan of abdomen with contrast (HCPCS:74160)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Phosphate level (HCPCS:84100)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Folic acid level, serum (HCPCS:82746)

The enumeration date for this NPI number is 1/12/2006 and was last updated on 8/3/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology210713-1NEW YORKYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
101891689MEDICAIDNEW YORK

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.